The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Learn all about psoriasis, a chronic inflammatory disease, including common symptoms, treatments, plus which diet and ...

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...

Alumis has concluded enrolment in its pivotal Phase III ONWARD programme of ESK-001 for treating plaque psoriasis.

Ben Griffin, fresh from his triumph in Texas last week, fired a seven-under-par 65 to grab a two-shot lead after the first ...

Using social media as a pharma brand can feel risky due to regulatory constraints - but it can make a big impact when used in ...

Studies show that people with psoriasis, especially those with severe cases, have a much higher risk of heart disease than ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations (autoinjector, prefilled syringe, and single-dose vial) of ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

Some 3.6 million Americans are diagnosed with basal cell carcinoma each year, according to the Skin Cancer Foundation.

Highroller Casino has quickly emerged as the premier destination for players seeking online casino games that truly pay real ...